Dr. Ramandeep Singh Arora Paediatric Oncologist
Doctor Overview
- Full Name & Designation: Dr. Ramandeep Singh Arora, Associate Director
- Specialization(s): Pediatric Oncology (Paed Onco), Medical Oncology, Pediatric Hematology, Musculoskeletal Oncology, Neuro Oncology, Hematology Oncology
- Years of Experience: 24+ years of experience
- Current Hospital/Institution Affiliation: Max Super Speciality Hospital, Saket, New Delhi
Dr. Ramandeep Singh Arora is a highly respected and experienced Associate Director specializing in Pediatric Oncology. With over 24 years of dedicated practice, Dr. Ramandeep Singh Arora, Pediatrician and Oncologist, brings a wealth of knowledge from his extensive training in India and the UK. As a leading Consultant Pediatric Oncologist, he focuses on providing comprehensive care for children and adolescents diagnosed with various cancers, including leukemia, lymphoma, brain tumors, and sarcomas. Dr. Arora (Paed Onco) is deeply committed to advancing pediatric cancer care through clinical practice, research, and his involvement in national and international oncology groups, striving to improve outcomes for young patients in India and globally. His expertise spans medical oncology, pediatric hematology, and specialized areas like musculoskeletal and neuro-oncology.
Qualifications & Credentials of Dr. Raman Arora
Medical Degrees:
- MBBS, Christian Medical College, Ludhiana, India (1998)
- Diploma in Child Health (DCH), Safdarjung Hospital, New Delhi (2001)
- MD (Cancer Epidemiology), University of Manchester, UK
Fellowships & Special Training:
- Paediatric Oncology Fellow, Alder Hey Children’s Hospital, Liverpool, UK
- Clinical Research Fellow, CRUK Paediatric & Familial Cancer Research Group, University of Manchester, UK
Certifications & Accreditations:
- MRCPCH (Paediatrics), Royal College of Paediatrics and Child Health, London, UK (2004)
- CCT (Paediatrics), Royal College of Paediatrics and Child Health, London, UK
- FRCPCH (Paediatrics), Royal College of Paediatrics and Child Health, London, UK
- Medical Registration Verified
Areas of Expertise
Major Cancer Types Treated:
- Leukemia (ALL, AML)
- Lymphoma (Hodgkin & Non-Hodgkin)
- Brain Tumours
- Embryonal Tumours (e.g., Neuroblastoma, Wilms’ Tumour)
- Sarcomas (Bone and Soft Tissue, e.g., Ewing Sarcoma, Osteosarcoma, Rhabdomyosarcoma)
- Other solid tumours in children and adolescents
Sub-specialties:
- Pediatric Hematology-Oncology
- Musculoskeletal Oncology
- Neuro Oncology
- Global Oncology (focus on LMICs)
- Cancer Epidemiology
Advanced Procedures Performed:
- Chemotherapy (Systemic, Intrathecal)
- Stem Cell Transplantation support and referral coordination
- Diagnosis and Management of complex childhood cancers
Professional Experience
- Associate Director (Pediatric Oncology & Hematology), Max Healthcare, Saket, New Delhi (Present)
- Paediatric Oncology Fellow, Alder Hey Children’s Hospital, Liverpool, UK
- Registrar-Paediatric Oncology, Royal Manchester Children’s Hospital, Manchester, UK
- Clinical Research Fellow, CRUK Paediatric & Familial Cancer Research Group, University of Manchester, UK
- Registrar-Paediatrics, Mersey Deanery & North West Deanery, Liverpool & Manchester, UK
- Senior Resident, Moolchand Hospital, New Delhi
- Resident-Paediatrics, Safdarjung Hospital, New Delhi
Academic & Research Roles:
- Active researcher with numerous publications.
- Involved with global health initiatives like INPHOG (Indian Pediatric Oncology Group) and CANCaRe Africa.
- Contributor to international pediatric oncology guidelines and research collaborations.
Research & Publications
Dr. Arora is a prolific researcher with several publications, focusing on pediatric oncology, epidemiology, and global cancer care.
Published Papers in Medical Journals (Selected Recent Titles):
- Children with cancer in India: An ethical framework for practice (Dec 2024)
- Pediatric Mature B-Cell Non-Hodgkin Lymphomas in India: A Retrospective Multicenter Pooled Analysis (Nov 2024)
- The Children’s Oncology Group Long-Term Follow-Up Guidelines for Survivors (Apr 2024)
- Profile of Childhood Cancers From Hospital-Based Cancer Registries in India, 2012-19 (Jan 2024)
- INPOG-NB-18-01 Retrospective survey of real world outcomes of Paediatric neuroblastoma in India (Jan 2024)
- An assessment of childhood cancer care services in India – gaps, challenges and the way forward (Jun 2023)
- Impact of the COVID-19 Pandemic on the Psychological Well-Being of Health Care Professionals in India (Apr 2023)
Ongoing Clinical Trials Participation: Actively involved in multicenter research and clinical studies, particularly through INPHOG and international collaborations.
Patient Success Stories & Testimonials
“When our son was diagnosed with cancer, we were devastated. Dr. Ramandeep Arora’s expertise and calm reassurance gave us hope. He explained the treatment plan clearly and was always available for our questions. Today, our son is in recovering well, thanks to Dr. Arora and his wonderful team.” – Akshay K
“Travelling from abroad for my daughter’s tumour treatment was daunting, but Dr. Ramandeep Arora’s team made it manageable. His knowledge of the latest protocols combined with his genuine care for my child made all the difference. We felt supported every step of the way.” – R. Zain
“I highly recommend consulting Dr. Ramandeep for pediatric oncology cases.” – Shaan T.
Treatment Approach & Philosophy
- Patient-Centred Care: Dr. Singh focuses on the unique needs of the child and family, providing compassionate and holistic care. He utilizes the latest international and national treatment protocols and research findings.
- Technology & Innovation: Dr. Singh leverages advanced diagnostics and treatment modalities. He advocates for equitable access to quality cancer care for children, particularly in resource-limited settings.
Consultation Fees & Treatment Costs
Dr. Ramandeep Singh Arora’s consultation fee is around Rs.1200.
Overall treatment costs vary significantly based on the specific cancer diagnosis, stage, required therapies (chemotherapy, radiation, surgery, supportive care), duration of treatment, and hospital stay. Cancer Rounds offers financial counselling services to help families understand and manage treatment expenses.
International Patient Assistance
Cancer Rounds team provides dedicated services for international patients seeking treatment under Dr. Ramandeep Singh Arora:
- Language Support: Interpretation services can be arranged.
- Visa & Travel Assistance: Help with visa invitation letters and local travel/accommodation arrangements. Also, Assistance with appointments, coordination, and queries.
- Pre-treatment Virtual Consultations: Facility for initial consultations online before travelling.
Frequently Asked Questions (FAQs)
1. What conditions does Dr. Ramandeep Singh Arora specialise in?
Dr. Ramandeep Singh Arora specialises in all types of childhood cancers, including Leukemia, Lymphoma, Brain Tumours, Sarcomas, Neuroblastoma, Wilms’ Tumour, and other solid tumours in children and adolescents. He also manages pediatric hematological conditions.
2. How much experience does Dr. Ramandeep Arora have in Pediatric Oncology?
Dr. Ramandeep Singh Arora, Pediatrician and Oncologist, has over 24 years of overall medical experience, with a significant portion dedicated specifically to Pediatric Oncology, including extensive training and practice in the UK and India.
3. How can I book an appointment with Dr. Ramandeep Singh Arora (Paed Onco)?
You can book an appointment by calling Cancer Rounds team.
4. Does Cancer Rounds team offer support for international patients seeking treatment with Dr. Raman Arora?
Yes, Cancer Rounds team has a dedicated international patient services team offering visa assistance, travel arrangements, language support, and virtual consultations for patients coming to see specialists like Ramandeep Arora, Consultant Pediatric Oncologist.
5. Is Dr. Raman Arora involved in research?
Yes, Dr. Raman Arora is highly active in clinical research, with numerous publications in pediatric oncology, cancer epidemiology, and global oncology. He participates in national (INPHOG) and international research collaborations.
